Global Androgen Replacement Therapy Market: Industry Outlook 2024–2030

The global androgen replacement therapy (ART) market was valued at USD 7.46 billion in 2024 and is projected to reach USD 7.99 billion by 2025, with further growth expected to USD 11.24 billion by 2030 at a compound annual growth rate (CAGR) of 7.06% from 2025 to 2030. Market expansion is driven primarily by increasing prevalence of metabolic disorders, obesity, and age-related testosterone deficiency among men. Rising awareness and diagnosis of hypogonadism, along with technological advancements in testosterone delivery systems, support therapy adoption. Regulatory developments, particularly FDA labeling updates, are influencing prescribing practices, emphasizing safety and cardiovascular monitoring. The market landscape is characterized by a mix of established pharmaceutical leaders and specialized innovators, with significant regional variations influenced by healthcare infrastructure, technological readiness, and demographic trends. This report provides an in-depth analysis of market segmentation, regional outlook, key drivers, inhibitors, and investment opportunities shaping the future of ART.